Disease | neuropathy, peripheral |
Comorbidity | C0031542|phlebitis |
Sentences | 1 |
PubMedID- 22069744 | Further phase i clinical trials demonstrated dose limiting toxicities in the form of myelosuppression and phlebitis, with moderate peripheral neuropathy. |
Page: 1